Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
Rhea-AI Summary
Avantor (NYSE: AVTR) will release its fourth quarter and full year 2025 financial results before market open on Wednesday, February 11, 2026. The company will host a conference call the same day at 8:00 a.m. Eastern Standard Time to discuss the results. Investors can listen via a live audio webcast on the Investor Events & Presentations page at ir.avantorsciences.com. A replay of the webcast will be available for 30 days following the live session.
Positive
- None.
Negative
- None.
News Market Reaction – AVTR
In the Jan 12 session, AVTR declined 1.05%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 05 | Conference participation | Positive | +3.8% | Announcement of CEO presentation at major J.P. Morgan healthcare conference. |
| Dec 18 | Board appointment | Positive | -0.3% | Addition of Simon Dingemans to board supporting Avantor Revival plan. |
| Dec 04 | Board appointment | Positive | -2.0% | Appointment of Sanjeev Mehra to board to aid growth and profitability. |
| Nov 25 | Innovation award | Positive | +3.0% | Edison Patent Award for sustainable viral inactivation detergent with Amgen. |
| Nov 19 | Facility expansion | Positive | -1.2% | Opening of Watertown centralized service center to support Boston labs. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company-specific announcements, especially awards and investor events, often coincided with positive price moves, while management and board changes saw more mixed or negative reactions.
Over the last few months, Avantor announced board additions linked to the Avantor Revival plan, expanded its Centralized Service Center model with a new Boston-area facility, and received a 2025 Edison Patent Award for sustainable viral inactivation technology. It also highlighted participation in the 44th Annual J.P. Morgan Healthcare Conference. These updates show ongoing strategic, operational, and innovation efforts. Today’s earnings-date announcement fits into this pattern of regular investor communication and operational progress without introducing new financial figures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Investor Relations Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-to-report-fourth-quarter-and-full-year-2025-earnings-on-wednesday-february-11-2026-302647216.html
SOURCE Avantor and Financial News